Valeant Pharmaceuticals International, Inc. : Call Options and Put Options Securities Litigation
On or around 06/11/2018 (Ongoing date of last review)
Filing Date: June 06, 2018
According to the Complaint, Valeant Pharmaceuticals International, Inc. ("Valeant") is a pharmaceutical and medical device company that sells medical devices and pharmaceuticals in over 100 countries around the world. Valeant is one of the largest pharmaceutical companies in the United States.
The Complaint alleges that Defendants made numerous materially false and misleading statements and omissions of material facts to investors throughout the Class Period regarding: (1) Valeant’s business strategy and financial results; (2) Valeant’s relationship with entities over which the Company purported to have limited or no control; (3) the adequacy of the Company’s internal controls; and (4) Valeant’s commitment to compliance with governing laws and regulations.
Company & Securities Information
Defendant: Valeant Pharmaceuticals International, Inc.
Industry: Biotechnology & Drugs
Ticker Symbol: VRX
Company Market: New York SE
Market Status: Public (Listed)
About the Company & Securities Data
"Company" information provides the industry and sector classification and headquarters state for the primary company-defendant in the litigation. In general, "Securities" information provides the ticker symbol, market, and market status for the underlying securities at issue in the litigation.
In most cases, the primary company-defendant actually issued the securities that are the subject of the litigation, and the securities information and company information relate to the same entity. In a small subset of cases, however, the primary company-defendant is not the issuer (for example, cases against third party brokers/dealers), and the securities information and company information do not relate to the same entity.
First Identified Complaint
Timber Hill LLC, et al. v. Valeant Pharmaceuticals International, Inc., et al.